UHS
Universal Health Services, Inc.
NYSE · Healthcare · Medical - Care Facilities · US
$169.68
+0.28%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 18.1B | 17.4B | 15.8B | 14.3B | 13.4B |
| Cost of Revenue | 1.7B | 1.7B | 1.6B | 1.5B | 1.5B |
| Gross Profit | 16.4B | 15.7B | 14.2B | 12.7B | 11.9B |
| Operating Expenses | |||||
| R&D Expense | — | — | — | — | — |
| SG&A Expense | 8.5B | 8.2B | 7.7B | 7.2B | 6.9B |
| General & Admin Expense | 8.5B | 8.2B | 7.7B | 7.2B | 6.9B |
| Selling & Marketing Expense | — | — | — | — | — |
| Other Expenses | 5.9B | 5.5B | 4.9B | 4.3B | 4.0B |
| Total Operating Expenses | 14.4B | 13.7B | 12.6B | 11.6B | 10.9B |
| Cost and Expenses | 16.1B | 15.4B | 14.1B | 13.1B | 12.4B |
| Operating Income (EBIT) | 2.1B | 2.0B | 1.7B | 1.2B | 1.0B |
| Non-Operating | |||||
| Interest Income | 524.0K | 1.2M | 1.4M | 572.0K | 378.0K |
| Interest Expense | 155.7M | 157.3M | 187.5M | 207.2M | 127.3M |
| Net Interest Income | (155.2M) | (156.1M) | (186.1M) | (206.7M) | (126.9M) |
| Other Non-Op Income/Expense | (31.9M) | (21.9M) | (183.9M) | (235.0M) | (137.3M) |
| Non-Operating Income (excl Interest) | (120.2M) | (130.4M) | 1.4M | 28.3M | 10.4M |
| EBT (Pre-Tax Income) | 2.0B | 2.0B | 1.5B | 940.4M | 866.3M |
| Income Tax Expense | 476.4M | 461.0M | 334.8M | 221.1M | 209.3M |
| Bottom Line | |||||
| Net Income | 1.5B | 1.5B | 1.1B | 717.8M | 675.6M |
| Earnings from Cont. Ops | 1.6B | 1.5B | 1.2B | 719.3M | 657.0M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 1.5B | 1.5B | 1.1B | 717.5M | 674.9M |
| Per Share | |||||
| Basic EPS | $24.66 | $23.42 | $17.16 | $10.35 | $9.23 |
| Diluted EPS | $24.38 | $23.10 | $16.82 | $10.23 | $9.14 |
| Revenue Per Share | $303.72 | $273.11 | $237.82 | $206.03 | $183.26 |
| Shares | |||||
| Basic Shares Outstanding | 59.6M | 63.6M | 66.6M | 69.3M | 73.1M |
| Diluted Shares Outstanding | 59.9M | 64.5M | 67.9M | 70.1M | 73.8M |
| Profitability Metrics | |||||
| EBITDA | 2.8B | 2.7B | 2.3B | 1.7B | 1.6B |
| D&A | 641.2M | 618.7M | 584.8M | 568.0M | 581.9M |
| EBIT | 2.2B | 2.1B | 1.7B | 1.1B | 993.1M |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026